259 related articles for article (PubMed ID: 35269645)
1. Atherosclerosis in HIV Patients: What Do We Know so Far?
Poznyak AV; Bezsonov EE; Borisov EE; Grechko AV; Kartuesov AG; Orekhov AN
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269645
[TBL] [Abstract][Full Text] [Related]
2. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
3. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
4. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.
Kearns A; Gordon J; Burdo TH; Qin X
J Am Coll Cardiol; 2017 Jun; 69(25):3084-3098. PubMed ID: 28641798
[TBL] [Abstract][Full Text] [Related]
5. Calcium score in the evaluation of atherosclerosis in patients with HIV/AIDS.
Monteiro VS; Lacerda HR; Uellendahl M; Chang TM; Albuquerque VM; Zirpoli JC; Ximenes RA; Albuquerque Mde F; Miranda Filho Dde B; Sobral Filho D
Arq Bras Cardiol; 2011 Nov; 97(5):427-33. PubMed ID: 21971633
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of atherosclerotic coronary artery disease in HIV patients.
Hakeem A; Bhatti S; Cilingiroglu M
Curr Atheroscler Rep; 2010 Mar; 12(2):119-24. PubMed ID: 20425247
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis in HIV patients: a new face for an old disease?
Maggi P; Maserati R; Antonelli G
AIDS Rev; 2006; 8(4):204-9. PubMed ID: 17219735
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
Magen E; Elbirt D; Sthoeger Z
Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
Sendi P; Günthard HF; Simcock M; Ledergerber B; Schüpbach J; Battegay M;
PLoS One; 2007 Jan; 2(1):e173. PubMed ID: 17245449
[TBL] [Abstract][Full Text] [Related]
10. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
Santinelli L; De Girolamo G; Borrazzo C; Vassalini P; Pinacchio C; Cavallari EN; Statzu M; Frasca F; Scordio M; Bitossi C; Viscido A; Ceccarelli G; Mancone M; Mastroianni CM; Antonelli G; d'Ettorre G; Scagnolari C
J Med Virol; 2021 Aug; 93(8):4930-4938. PubMed ID: 33913525
[TBL] [Abstract][Full Text] [Related]
11. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population.
Wandeler G; Johnson LF; Egger M
Curr Opin HIV AIDS; 2016 Sep; 11(5):492-500. PubMed ID: 27254748
[TBL] [Abstract][Full Text] [Related]
12. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
13. Prevention of atherosclerosis in patients living with HIV.
De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H
Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
15. [Antiretroviral therapy].
von Braun A; Furrer H; Battegay M; Calmy A; Cavassini M; Vernazza P; Bernasconi E; Weber R; Günthard HF
Ther Umsch; 2014 Aug; 71(8):461-8. PubMed ID: 25093310
[TBL] [Abstract][Full Text] [Related]
16. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
[TBL] [Abstract][Full Text] [Related]
17. Authors' Reply: association of HIV-infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis.
Gómez-Garre D; Estrada V; Ortega-Hernández A; Muñoz-Pacheco P; Serrano-Villar S; Avila M; Fuentes-Ferrer M; Tejerina T; Fernández-Cruz A
J Acquir Immune Defic Syndr; 2013 Jan; 62(1):e23-5. PubMed ID: 23262979
[No Abstract] [Full Text] [Related]
18. The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients.
Lo J; Plutzky J
J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S368-74. PubMed ID: 22577210
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
